A working laboratory notebook on innate and adaptive defense, the antibody Y, vaccines, and the ways the immune system mistakes self for enemy.
// Every cubic millimeter of you is contested territory.
// Your body distinguishes self from non-self, then acts.
The immune system is the body's distributed network for detecting and neutralizing threats — bacteria, viruses, fungi, parasites, malignant cells, and foreign matter. It operates in two coordinated layers: the innate system (fast, broad, hard-coded) and the adaptive system (slow, specific, memory-forming).
Together they manage roughly 10²⁵ pathogen exposures over a human lifetime — most without our notice. Failures produce three categories of disease: immunodeficiency (too little response), allergy (response to harmless triggers), and autoimmunity (response against self).
The innate system responds in minutes to hours. Its receptors (TLRs, NLRs, RIG-I-like) recognize pathogen-associated molecular patterns (PAMPs) — features common to many pathogens, like bacterial LPS or viral dsRNA.
// FIG_2.1 immune cells in tissue (idealized)
Adaptive immunity needs ~5–7 days for a primary response — the cost of specificity. Two arms:
| Arm | Cell | Mechanism |
|---|---|---|
| Humoral | B cells → plasma cells | Secrete antibodies; recognize free antigen |
| Cell-mediated | T cells | CD8+ kill infected cells; CD4+ helper coordinate |
Each B and T cell expresses a unique receptor generated by V(D)J recombination — Susumu Tonegawa won the 1987 Nobel for showing how a few hundred genes can produce ~10¹¹ distinct receptors. The body holds an enormous lottery; pathogen-binding receptors get selected and cloned.
// FIG_4.1 IgG monomer
Antibodies (immunoglobulins) are Y-shaped proteins with two identical antigen-binding sites (Fab) and a constant region (Fc) that determines class and effector function.
| Class | Role |
|---|---|
| IgG | ~75% of serum Ig; secondary response; crosses placenta. |
| IgM | First responder; pentameric; complement activation. |
| IgA | Mucosal surfaces (gut, lung, breast milk). |
| IgE | Allergy, parasite defense. |
| IgD | B-cell receptor; function partly unclear. |
The major histocompatibility complex (MHC; HLA in humans) presents protein fragments on cell surfaces for inspection by T cells. Class I MHC is on every nucleated cell — it shows what's being made inside (intracellular surveillance). Class II MHC is on antigen-presenting cells — it shows what's been ingested from outside.
HLA is the most polymorphic gene region in the human genome — driven by long-running co-evolution with pathogens. It determines tissue-graft compatibility and influences susceptibility to autoimmune disease (HLA-B27 / ankylosing spondylitis; HLA-DR / type 1 diabetes; HLA-B*57:01 / abacavir hypersensitivity).
| Type | Mechanism | Examples |
|---|---|---|
| Live attenuated | Weakened pathogen replicates, induces robust response | MMR, varicella, oral polio, yellow fever |
| Inactivated | Killed pathogen; needs adjuvant + boosters | Hepatitis A, rabies, IPV, flu shot |
| Subunit / recombinant | Specific antigen produced in vitro | Hepatitis B, HPV, acellular pertussis |
| Toxoid | Inactivated bacterial toxin | Tetanus, diphtheria |
| Conjugate | Polysaccharide + carrier protein | Hib, pneumococcal, meningococcal |
| Viral vector | Harmless virus carries antigen gene | Ebola (VSV), some COVID-19 |
| mRNA | Lipid nanoparticle delivers mRNA encoding antigen | COVID-19 (Pfizer, Moderna) |
// "Vaccines have probably saved more lives than any single medical intervention." — Stanley Plotkin, vaccinologist.
Self-tolerance fails in autoimmune disease — the immune system targets the body's own tissues. Affects ~5–10% of populations; women disproportionately. Mechanisms include genetic predisposition, molecular mimicry (pathogen antigen resembles self), and bystander activation.
Coombs and Gell's classification (1963) describes four mechanisms by which immune responses cause harm:
| Type | Mediator | Example |
|---|---|---|
| I — Immediate | IgE → mast cell degranulation | Anaphylaxis, hay fever, asthma |
| II — Cytotoxic | IgG/IgM bind cell-surface antigen | Transfusion reaction, hemolytic disease |
| III — Immune complex | Antigen-antibody complex deposits | Serum sickness, lupus nephritis |
| IV — Delayed | T-cell mediated | Contact dermatitis, TB skin test |
// FIG_9.1 enveloped RNA virus (idealized SARS-CoV-2 schematic)
Viruses are obligate intracellular parasites — genetic material (DNA or RNA) wrapped in a protein capsid, sometimes with a lipid envelope. Surface proteins (spike, HA, gp120) bind host receptors; the immune system targets these.
Antibodies that bind spike-like proteins prevent receptor engagement — neutralizing antibodies. Most COVID-19 vaccines train this response. Why protection wanes: antibody titers fall over months; viral evolution alters the spike (immune escape).
Tumors hide from T cells partly by expressing PD-L1, which binds PD-1 on T cells and switches them off. Antibodies against PD-1 (pembrolizumab, nivolumab) or PD-L1 release the brake. James Allison and Tasuku Honjo won the 2018 Nobel for this insight, which has produced durable remissions in melanoma, lung cancer, and other malignancies — though only ~20–40% of patients respond.
CAR-T therapy goes further: T cells are removed, genetically engineered to recognize a tumor antigen (typically CD19 for B-cell malignancies), expanded, and reinfused. Approved since 2017 (tisagenlecleucel) for refractory leukemias and lymphomas.
Modern immunology lives in flow cytometers, single-cell sequencers, structural biology, and increasingly computational pipelines — but a portion of every paper still depends on cells in dishes and antibodies on bench tops.
Osmosis (now part of Elsevier) produces clear, illustrated medical-education videos. Their immunology playlist covers innate, adaptive, antibodies, complement, and major disorders.
Also: Khan Academy Medicine — Immunology series (free); Kuby Immunology textbook (Punt et al., 8th ed.); Janeway's Immunobiology (10th ed., Murphy & Weaver).
The basic mechanisms described here — innate/adaptive arms, antibody classes, V(D)J recombination, MHC presentation, vaccine principles — are extremely well established and form the consensus textbook account. Active research areas with greater uncertainty: tumor immune evasion, microbiome-immune interactions, mechanisms of long COVID and post-acute infection syndromes, the role of inflammation in aging.
// Educational content. Diagnoses involving immune disease require specialist evaluation. Vaccines, immunosuppressants, and biologics are powerful tools used under medical supervision.